Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research... Show more
Industry ServicestotheHealthIndustry
A.I.dvisor indicates that over the last year, SOPH has been loosely correlated with TEM. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if SOPH jumps, then TEM could also see price increases.
| Ticker / NAME | Correlation To SOPH | 1D Price Change % | ||
|---|---|---|---|---|
| SOPH | 100% | -10.00% | ||
| TEM - SOPH | 35% Loosely correlated | -13.85% | ||
| RIOT - SOPH | 32% Poorly correlated | -2.02% | ||
| COIN - SOPH | 30% Poorly correlated | -1.32% | ||
| SDGR - SOPH | 29% Poorly correlated | -11.35% | ||
| MNDR - SOPH | 29% Poorly correlated | -6.20% | ||
More | ||||
| Ticker / NAME | Correlation To SOPH | 1D Price Change % |
|---|---|---|
| SOPH | 100% | -10.00% |
| Services to the Health Industry industry (42 stocks) | 18% Poorly correlated | -1.58% |
| Health Services industry (241 stocks) | 3% Poorly correlated | -1.19% |
Be on the lookout for a price bounce soon.
Following a +2.12% 3-day Advance, the price is estimated to grow further. Considering data from situations where SOPH advanced for three days, in 202 of 242 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.
SOPH may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 119 of 129 cases where SOPH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 90%.
The Momentum Indicator moved below the 0 level on October 01, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SOPH as a result. In 105 of 117 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
The Moving Average Convergence Divergence Histogram (MACD) for SOPH turned negative on August 31, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 55 similar instances when the indicator turned negative. In 51 of the 55 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
SOPH moved below its 50-day moving average on October 06, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SOPH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
The Tickeron Price Growth Rating for this company is 36 (best 1 - 100 worst), indicating steady price growth. SOPH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 40 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.696) is normal, around the industry mean (7.432). SOPH has a moderately low P/E Ratio (0.000) as compared to the industry average of (46.656). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.133). Dividend Yield (0.000) settles around the average of (0.010) among similar stocks. P/S Ratio (6.452) is also within normal values, averaging (6.065).
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SOPH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 98, placing this stock worse than average.